Skip to main content

Table 4 Regional hemodynamics

From: Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

  Baseline 12 hours 24 hours 36 hours 48 hours
CBI
(mL/min/m)
     
TP 353 ± 226 387 ± 202 367 ± 179 299 ± 139 351 ± 129
AVP 397 ± 171 409 ± 209 367 ± 222 308 ± 185* 305 ± 201*
NE 327 ± 135 358 ± 173 312 ± 145 271 ± 136 252 ± 206
PDR
(%)
     
TP 13 ± 6 14 ± 5 13 ± 4 12 ± 5 13 ± 4
AVP 15 ± 5 15 ± 6 13 ± 7 12 ± 7* 11 ± 6*
NE 14 ± 5 13 ± 5 12 ± 6 11 ± 6* 10 ± 7*
P g-a CO 2
(mmHg)
     
TP 23 ± 11 24 ± 8 22 ± 6 20 ± 6 20 ± 7
AVP 25 ± 7 28 ± 8 27 ± 9 28 ± 12 28 ± 10
NE 24 ± 11 28 ± 10 28 ± 8 26 ± 8 31 ± 12
Urinary output
(mL/h)
     
TP 34.6 ± 31.3 69.3 ± 70.4 49.2 ± 49.5 48.5 ± 41.4 46.6 ± 33.3
AVP 42.3 ± 46.9 42 ± 39 42 ± 41.6 40.7 ± 45.7 43.3 ± 58.7
NE 38.6 ± 34.3 55.4 ± 74.1 66 ± 77 58.6 ± 56.1 58.6 ± 63.8
  1. AVP = arginine vasopressin; CBI = blood clearance of indocyanine green; NE = norepinephrine; PDR = plasma disappearance rate of indocyanine green; Pg-aCO2 = gastric-mucosal arterial carbon dioxide partial pressure difference; TP = terlipressin.
  2. * P < 0.05 vs. baseline (significant time effect); P < 0.05 vs. TP (significant group effect); P < 0.05 vs. AVP (significant group effect); § P < 0.05 vs. NE (significant group effect).